Cargando…
Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances
BACKGROUND/OBJECTIVE: Anorexigenic palmitoylated prolactin-releasing peptide (palm(11)-PrRP) is able to act centrally after peripheral administration in rat and mouse models of obesity, type 2 diabetes mellitus and/or neurodegeneration. Functional leptin and intact leptin signaling pathways are nece...
Autores principales: | Mráziková, Lucia, Hojná, Silvie, Pačesová, Andrea, Hrubá, Lucie, Strnadová, Veronika, Neprašová, Barbora, Železná, Blanka, Kuneš, Jaroslav, Maletínská, Lenka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119973/ https://www.ncbi.nlm.nih.gov/pubmed/35589696 http://dx.doi.org/10.1038/s41387-022-00205-3 |
Ejemplares similares
-
Metabolomic Study of Aging in fa/fa Rats: Multiplatform Urine and Serum Analysis
por: Pelantová, Helena, et al.
Publicado: (2023) -
Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models
por: Mráziková, Lucia, et al.
Publicado: (2021) -
Age-related metabolic and neurodegenerative changes in SAMP8 mice
por: Pačesová, Andrea, et al.
Publicado: (2022) -
Palmitoylation of Prolactin-Releasing Peptide Increased Affinity for and Activation of the GPR10, NPFF-R2 and NPFF-R1 Receptors: In Vitro Study
por: Karnošová, Alena, et al.
Publicado: (2021) -
Lipidized PrRP Analog Exhibits Strong Anti-Obesity and Antidiabetic Properties in Old WKY Rats with Obesity and Glucose Intolerance
por: Mráziková, Lucia, et al.
Publicado: (2023)